Eugene Paschold

987 total citations
12 papers, 592 citations indexed

About

Eugene Paschold is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eugene Paschold has authored 12 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eugene Paschold's work include Neuroendocrine Tumor Research Advances (2 papers), Lung Cancer Research Studies (2 papers) and Cancer therapeutics and mechanisms (2 papers). Eugene Paschold is often cited by papers focused on Neuroendocrine Tumor Research Advances (2 papers), Lung Cancer Research Studies (2 papers) and Cancer therapeutics and mechanisms (2 papers). Eugene Paschold collaborates with scholars based in United States, Germany and France. Eugene Paschold's co-authors include Donald Woytowitz, Michael McCleod, Robert C. Hermann, Taral Patel, Shaker R. Dakhil, Martin R. Weber, Luke Dreisbach, Nicholas Iannotti, W. Heim and Thomas J. Lynch and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Eugene Paschold

12 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eugene Paschold United States	8	428	347	154	83	50	12	592
Monika Dufmats Sweden	12	375 0.9×	231 0.7×	125 0.8×	198 2.4×	69 1.4×	13	619
Moshe Mishaeli Israel	9	357 0.8×	253 0.7×	248 1.6×	117 1.4×	24 0.5×	27	591
C Mossetti Italy	13	380 0.9×	350 1.0×	131 0.9×	77 0.9×	39 0.8×	31	745
Manabu Yamamoto Japan	11	237 0.6×	253 0.7×	160 1.0×	97 1.2×	34 0.7×	26	556
Vincenzo Emanuele Chiurì Italy	12	478 1.1×	456 1.3×	213 1.4×	189 2.3×	34 0.7×	35	703
Ramón Palmero Spain	14	384 0.9×	328 0.9×	159 1.0×	79 1.0×	14 0.3×	50	646
Lambros Vamvakas Greece	17	597 1.4×	370 1.1×	114 0.7×	164 2.0×	18 0.4×	44	759
Kuniko Sunami Japan	16	320 0.7×	297 0.9×	150 1.0×	196 2.4×	30 0.6×	47	638
Ji Zhou China	16	292 0.7×	174 0.5×	129 0.8×	91 1.1×	37 0.7×	39	621
Janice F. Eakle United States	9	565 1.3×	345 1.0×	246 1.6×	265 3.2×	78 1.6×	22	805

Countries citing papers authored by Eugene Paschold

Since Specialization

Citations

This map shows the geographic impact of Eugene Paschold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Paschold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Paschold more than expected).

Fields of papers citing papers by Eugene Paschold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Paschold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Paschold. The network helps show where Eugene Paschold may publish in the future.

Co-authorship network of co-authors of Eugene Paschold

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Paschold. A scholar is included among the top collaborators of Eugene Paschold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Paschold. Eugene Paschold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Rajan, Arun, Jhanelle E. Gray, Siddhartha Devarakonda, et al.. (2019). Phase I trial of CV301 in combination with anti-PD-1 therapy in non-squamous NSCLC. Annals of Oncology. 30. v493–v494. 1 indexed citations

Paschold, Eugene, Julien Mazières, H. Léna, et al.. (2012). A randomized, double-blinded, phase II study of paclitaxel/carboplatin (PC) plus CT-322 versus PC plus bevacizumab (Bev) as first-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 30(15_suppl). 7584–7584. 2 indexed citations

Pawel, Joachim von, Robert M. Jotte, Eugene Paschold, et al.. (2012). Randomized phase 3 trial of amrubicin versus topotecan as second-line treatment for small cell lung cancer (SCLC). Pneumologie. 66(S 01). 2 indexed citations

Jotte, Robert M., Joachim von Pawel, David R. Spigel, et al.. (2011). Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC).. Journal of Clinical Oncology. 29(15_suppl). 7000–7000. 40 indexed citations

Wong, Kwok‐Kin, Eugene Paschold, Leora Horn, et al.. (2011). An open-label phase II study of the Hsp90 inhibitor ganetespib (STA-9090) as monotherapy in patients with advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 29(15_suppl). 7500–7500. 47 indexed citations

Lynch, Thomas J., Taral Patel, Luke Dreisbach, et al.. (2010). Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099. Journal of Clinical Oncology. 28(6). 911–917. 338 indexed citations

Thompson, James T., Eugene Paschold, & Edward A. Levine. (2001). Paraneoplastic Hypercalcemia in a Patient with Adenosquamous Cancer of the Colon. The American Surgeon. 67(6). 585–588. 12 indexed citations

Muss, Hyman B., H. Bradley Wells, Eugene Paschold, et al.. (1988). Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.. Journal of Clinical Oncology. 6(7). 1098–1106. 61 indexed citations

Muss, H. B., Philip Bonomi, Jamie Von Roenn, et al.. (1988). Megestrol acetate as primary hormonal therapy for advanced breast cancer.. PubMed. 15(2 Suppl 1). 34–43. 10 indexed citations

10.

Jackson, Don V., M. Robert Cooper, James N. Atkins, et al.. (1986). Clinical trial of pyridoxine to reduce vincristine neurotoxicity. Journal of Neuro-Oncology. 4(1). 37–41. 38 indexed citations

11.

Paschold, Eugene, et al.. (1986). Operative technique for insertion of a totally implantable system for venous access.. PubMed. 163(4). 381–2. 5 indexed citations

12.

Jackson, Don V., Eugene Paschold, Charles L. Spurr, et al.. (1984). Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion. Cancer. 53(12). 2601–2606. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact